[Efficient synthesis of 3'-amino-3'-deoxythymidine derivatives]. 2005

K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets

An efficient method of reduction of 3'-azido-3'-deoxythymidine and its 5'-protected derivatives to 3'-aminothymidine derivatives on a palladium catalyst using ammonium formate as a source of hydrogen was suggested.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides

Related Publications

K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
December 1973, The Journal of organic chemistry,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
February 2011, Tetrahedron letters,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
February 1992, Molecular pharmacology,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
January 2004, Bioorganicheskaia khimiia,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
August 1996, Journal of medicinal chemistry,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
May 1996, Journal of immunoassay,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
November 1984, Journal of pharmaceutical sciences,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
June 1992, Clinical pharmacology and therapeutics,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
June 2004, Organic letters,
K V Seregin, and M V Chudinov, and A M Iurkevich, and V I Shvets
May 1984, Molecular pharmacology,
Copied contents to your clipboard!